Results 51 to 60 of about 49,424 (197)

Management of Non‐Plaque‐Induced Gingival Conditions: A Systematic Review—Part 2: Inflammatory and Immune Conditions; Neoplasms; and Gingival Pigmentation

Journal of Clinical Periodontology, EarlyView.
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra, Cecile Wasielewski, Bruno Špiljak, Maja Sabalić‐Schoener, Sebastien Jungo, Ivan Alajbeg   +5 more
wiley   +1 more source

Analysis of proliferative activity in oral gingival epithelium in immunosuppressive medication induced gingival overgrowth

Head & Face Medicine, 2006
Background Drug-induced gingival overgrowth is a frequent adverse effect associated principally with administration of the immunosuppressive drug cyclosporin A and also certain antiepileptic and antihypertensive drugs.
Özdemir B Handan, Uslu Hilal, Bulut Şule, Bulut Ömer   +3 more
doaj   +1 more source

Systemic Therapy for Paediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review of Current Evidence and Limitations

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim The role of systemic therapy in paediatric Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) remains undefined. Management is primarily guided by observational data and variable practice patterns. This systematic review aims to integrate recent evidence and evaluate clinical outcomes associated with systemic therapies in ...
Samantha Ting, Kangjie Reuel Chua, Li‐Chuen Wong, Gloria Fong   +3 more
wiley   +1 more source

Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin

Frontiers in Oncology, 2020
Anemia associated with Immune checkpoint inhibitor (ICI) is usually hemolytic and regenerative. Cases of non-regenerative pure red cell aplasia are rare, and typically improve upon drug discontinuation and after corticotherapy. We herein report a case of
Alexandre Gérard, Serena Romani, Elise Van-Obberghen, Audrey Fresse, Marine Muzzone, Nadège Parassol, Annick Boscagli, Fanny Rocher, Delphine Borchiellini, Milou-Daniel Drici   +9 more
doaj   +1 more source

Peri‐Implant Soft‐Tissue Phenotype Modification for Refractory Peri‐Implant Mucositis: A 12‐Month Prospective Clinical Study With Ultrasonographic Analysis

Journal of Periodontal Research, EarlyView.
Surgical treatment of refractory peri‐implant mucositis with a free gingival graft (FGG) was effective in disease resolution, achieving reductions in probing pocket depth (PPD) and inflammation. Significant gains in mucosal thickness (MT) and keratinized mucosa width (KMW), as well as partial recession coverage and re‐establishment of attached mucosa ...
Shayan Barootchi, Lorenzo Tavelli, Hamoun Sabri, Hom‐Lay Wang, Erfan Barootchi, Mario Romandini, Istvan A. Urban, Zoltan Barath   +7 more
wiley   +1 more source

The role of acquired host immunity in periodontal diseases

Periodontology 2000, EarlyView.
Abstract The aim of this narrative review is to relate the contribution of European researchers to the complex topic of the host immune system in periodontal disease, focusing on acquired immunity. Other chapters in this volume will address the genetics and autoantibody responses and other forms of immunity to periodontal disease.
Denis F. Kinane, David F. Lappin, Shauna Culshaw   +2 more
wiley   +1 more source

Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome

Терапевтический архив, 2010
Aim. To evaluate the efficacy of cyclosporin A (CsA) in patients with myelodysplastic syndromes (MDS) and to identify determinants of a response to this therapy. Subjects and methods.
A V Kokhno, E N Parovichnikova, E A Mikhailova, E N Ustinova, I B Kaplanskaya, V N Dvirnyk, Yu V Olshanskaya, E V Domracheva, V G Savchenko   +8 more
doaj  

Improvement of Kidney Injury Molecule-1 (KIM-1) and N-Acetylglucosamindase (NAG) in the Kidney Following Platelet Rich Plasma (PRP) Administration in the Treatment of Cyclosporine A-Induced Nephrotoxicity in Adult Male Albino Rats [PDF]

The Egyptian Journal of Histology
Introduction: Cyclosporin A (CsA) is a drug used to suppress the immune system thus treating rejection of transplantation and autoimmune diseases. However, adverse effects limit its use in clinical practice.
Tarek Abdel Galil, Soheir Elsharouny, Mohamed Shaaban, Hadeer Tohamy, Sarah Kaooh   +4 more
doaj   +1 more source

Epidemiology and Outcomes of Cryptococcal Infections in Liver Transplant Recipients: A Retrospective Cohort Study at a US Academic Center

Transplant Infectious Disease, EarlyView.
Among 346 liver transplant recipients, rural residence conferred a 3.3‐fold higher risk of cryptococcal infection — a novel finding suggesting environmental exposure or healthcare access barriers may drive susceptibility. Triple immunosuppression and longer waitlist duration were additional risk factors, with very early infection carrying the worst ...
Rachel Sigler, Chloe Hanigan, Atikur Rahman, Isuru Ratnayake, Phani Akella, Lauren Carlini, Chelsea Gorsline, Erica Mackenzie, Albert Eid, Dennis Shoemaker, Ryan Taylor, Stephen Waller   +11 more
wiley   +1 more source

Treatment of atopic dermatitis with cyclosporin A: a case report

Przegląd Dermatologiczny, 2017
Introduction . Despite the progress that has been made in the therapy of atopic dermatitis in recent years, cyclosporin A remains the first-line treatment of severe forms of the disease. Objective.
Karolina Kaaz, Adam Reich
doaj   +1 more source